Open AccessOptimization of MR Imaging for Pretreatment Evaluation of Patients with Endometrial and Cervical Cancer
Author(s) -
Gaiane M. Rauch,
Harmeet Kaur,
Haesun Choi,
Randy D. Ernst,
Ann H. Klopp,
Piyaporn Boonsirikamchai,
Shan N. Westin,
Leonardo P. Marcal
Publication year - 2014
Publication title -
radiographics
Language(s) - English
Resource type - Journals
eISSN - 1527-1323
pISSN - 0271-5333
DOI - 10.1148/rg.344140001
Subject(s) - medicine , parametrial , magnetic resonance imaging , endometrial cancer , radiology , cervical cancer , cancer , cervical carcinoma
Endometrial and cervical cancer are the most common gynecologic malignancies in the world. Accurate staging of cervical and endometrial cancer is essential to determine the correct treatment approach. The current International Federation of Gynecology and Obstetrics (FIGO) staging system does not include modern imaging modalities. However, magnetic resonance (MR) imaging has proved to be the most accurate noninvasive modality for staging endometrial and cervical carcinomas and often helps with risk stratification and making treatment decisions. Multiparametric MR imaging is increasingly being used to evaluate the female pelvis, an approach that combines anatomic T2-weighted imaging with functional imaging (ie, dynamic contrast material-enhanced and diffusion-weighted imaging). MR imaging helps guide treatment decisions by depicting the depth of myometrial invasion and cervical stromal involvement in patients with endometrial cancer and tumor size and parametrial invasion in those with cervical cancer. However, its accuracy for local staging depends on technique and image quality, namely thin-section high-resolution multiplanar T2-weighted imaging with simple modifications, such as double oblique T2-weighting supplemented by diffusion weighting and contrast enhancement.